abeladrug200
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2010 (NCT00810940)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- abeladrug200
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00810940 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2010 | Abela Pharmaceuticals, Inc., Dr. Mahajan's Hospital & Industrial Trauma Centre, Ohio State University, University of California, Irvine |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Abela Pharmaceuticals, Inc. | For profit | 1 | 1 | 1 | 2010 |
| Dr. Mahajan's Hospital & Industrial Trauma Centre | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Ohio State University | Academic/Hospital | 1 | 0 | 1 | 2010 |
| University of California, Irvine | Academic/Hospital | 1 | 0 | 1 | 2010 |
4 organizations
Page 1 / 1